Gene · 1457
Papers3,014
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 3,014
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Signaling network analysis reveals fostamatinib as a potential drug to control platelet hyperactivation during SARS-CoV-2 infection. | Front Immunol | 2023 | 38187394 | PubTator, text mining | PubMed |
| Comprehensive analysis of mitophagy-related genes in NSCLC diagnosis and immune scenery: based on bulk and single-cell RNA sequencing data. | Front Immunol | 2023 | 38155968 | PubTator, text mining | PubMed |
| Formulation and Investigation of CK2 Inhibitor-Loaded Alginate Microbeads with Different Excipients. | Pharmaceutics | 2023 | 38140042 | PubTator, text mining | PubMed |
| Protein Kinase CK2α', More than a Backup of CK2α. | Cells | 2023 | 38132153 | PubTator, text mining | PubMed |
| The function of ER-phagy receptors is regulated through phosphorylation-dependent ubiquitination pathways. | Nat Commun | 2023 | 38102139 | PubTator, text mining | PubMed |
| Mapping protein states and interactions across the tree of life with co-fractionation mass spectrometry. | Nat Commun | 2023 | 38102123 | PubTator, text mining | PubMed |
| Exome sequencing in 16 patients with pituitary stalk interruption syndrome: A monocentric study. | PLoS One | 2023 | 38096238 | PubTator, text mining | PubMed |
| The Interaction of SRL-2 Peptide with LRP-1 Receptor and Identification of Breast Cancer Related Biomarkers: An In-silico Approach. | Iran J Pharm Res | 2023 | 38084295 | PubTator, text mining | PubMed |
| PML Body Biogenesis: A Delicate Balance of Interactions. | Int J Mol Sci | 2023 | 38069029 | PubTator, text mining | PubMed |
| Lower myostatin and higher MUC1 levels are associated with better response to mepolizumab and omalizumab in asthma: a protein-protein interaction analyses. | Respir Res | 2023 | 38057814 | PubTator, text mining | PubMed |
| GARP and EARP are required for efficient BoHV-1 replication as identified by a genome wide CRISPR knockout screen. | PLoS Pathog | 2023 | 38055775 | PubTator, text mining | PubMed |
| Functional and spatial proteomics profiling reveals intra- and intercellular signaling crosstalk in colorectal cancer. | iScience | 2023 | 38047086 | PubTator, text mining | PubMed |
| Expression of nonmuscle myosin IIC is regulated by non-canonical binding activity of miRNAs. | iScience | 2023 | 38047082 | PubTator, text mining | PubMed |
| Uncoupling p38α nuclear and cytoplasmic functions and identification of two p38α phosphorylation sites on β-catenin: implications for the Wnt signaling pathway in CRC models. | Cell Biosci | 2023 | 38041178 | PubTator, text mining | PubMed |
| Mitophagy genes in ovarian cancer: a comprehensive analysis for improved immunotherapy. | Discov Oncol | 2023 | 38038814 | PubTator, text mining | PubMed |
| Host kinase regulation of Plasmodium vivax dormant and replicating liver stages. | bioRxiv | 2023 | 38014051 | PubTator, text mining | PubMed |
| Phosphorylation of Human Polyomavirus Large and Small T Antigens: An Ignored Research Field. | Viruses | 2023 | 38005912 | PubTator, text mining | PubMed |
| A Strategy Utilizing Protein-Protein Interaction Hubs for the Treatment of Cancer Diseases. | Int J Mol Sci | 2023 | 38003288 | PubTator, text mining | PubMed |
| Chemo- and bio-informatics insight into anti-cholinesterase potentials of berries and leaves of Myrtus communis L., Myrtaceae: an in vitro/in silico study. | BMC Complement Med Ther | 2023 | 37990185 | PubTator, text mining | PubMed |
| Molecular and functional profiling of chemotolerant cells unveils nucleoside metabolism-dependent vulnerabilities in medulloblastoma. | Acta Neuropathol Commun | 2023 | 37978570 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1457/papers?page=6